Cloud saving enabled
Cloud saving enabled. Updates are stored securely and available across your devices.
JNJ Intelligence
Overview, health ratings, scorecard, and competition exposure
JNJ
NYSESeed fundamentalsJohnson & Johnson
Healthcare · Drug Manufacturers — General · United States
$158.00
Mkt cap $380B
Overview
Market Cap
$380B
Price
$158.00
52W High
$170.00
52W Low
$140.00
Avg Volume
7M
Dividend Yield
3.1%
Beta
0.55
Analyst Target
$170.00
Business Summary
Diversified healthcare company spanning pharmaceuticals and medtech.
Financial Health
Normalized category ratings with evidence — Unknown when inputs are missing
Each category rates only the metrics present for the company. Thresholds are deterministic rules (liquidity ratios, margins, growth rates, leverage, returns, cash flow, beta/short interest). Missing inputs yield Unknown for that category — values are never invented.
Liquidity
Good- Current ratio 1.2–2$1.2
- Net debt present (cash − debt)-$10B
Profitability
Excellent- ROE ≥ 25%25.0%
- Operating margin ≥ 25%25.0%
- Gross margin ≥ 50%69.0%
Growth
Fair- Revenue growth 3–12%4.0%
- EPS growth 0–10%6.0%
Balance Sheet
Excellent- Debt/Equity < 0.545.0%
- Cash below total debt$0.71
Capital Allocation
Excellent- ROIC 12–20%16.0%
- Positive free cash flow$18B
- Pays a dividend (allocation signal, not required)3.1%
Efficiency
Excellent- ROE ≥ 20%25.0%
- ROIC ≥ 15%16.0%
- Operating margin ≥ 20%25.0%
Cash Flow
Excellent- Positive free cash flow$18B
- Operating margin supports cash conversion25.0%
Risk
Excellent- Beta < 0.9 (lower market sensitivity)$0.55
- Short interest < 2%0.6%
- Low leverage45.0%
Growth
Revenue Growth
4.0%
EPS Growth
6.0%
PEG
2.5x
Valuation
P/E
15.5x
Forward P/E
14.0x
PEG
2.5x
Price/Sales
4.2x
Price/Book
5.0x
Profitability
ROE
25.0%
ROIC
16.0%
Operating Margin
25.0%
Gross Margin
69.0%
Free Cash Flow
$18B
Ownership
Institutional
70.0%
Insider
0.1%
Short Interest
0.6%
Analyst Rating
Hold
Risk
Beta
0.55
Debt/Equity
0.5x
Current Ratio
1.2
Cash
$25B
Debt
$35B
Short Interest
0.6%
Technical Overview
Price
$158.00
52W High
$170.00
52W Low
$140.00
Avg Volume
7M
Chart indicators and pattern detection are reserved for a later sprint.
Investment Scorecard
Transparent category scores — no single magical AI composite
Category scores are transparent and independent. There is no single composite AI score. Missing fundamentals reduce coverage; they do not fabricate a middle score.
Financial Health
All financial health categories had enough evidence to rate.
Average of Liquidity, Profitability, Growth, Balance Sheet, Capital Allocation, Efficiency, Cash Flow, and Risk ratings. Unknown categories are excluded (not filled with a neutral score).
Growth
Scored from revenueGrowth and epsGrowth.
Uses revenue growth and EPS growth bands. Higher sustained growth scores higher; negative EPS growth scores Weak.
Valuation
All valuation inputs present.
Average of P/E, Forward P/E, PEG, and Price/Sales bands. Lower multiples score higher. This is a mechanical screen, not a fair-value model.
Quality
Based on roe, roic, grossMargin.
Combines ROE, ROIC, and gross margin quality bands.
Risk
Beta, short interest, and leverage all available.
Higher scores mean lower measured risk from beta, short interest, and leverage. Not a volatility forecast.
Technical
Mechanical range/liquidity score; not investment advice.
Foundation heuristic only: 52-week range position plus liquidity (average volume). Not a chart pattern or indicator suite — reserved for future Technical Overview expansion.
Momentum
Proxy momentum only; not a returns-based momentum factor.
Proximity to 52-week high plus EPS growth as a fundamentals momentum proxy. No price time-series yet — extension point for Sprint 19+.
Recent News
News feed placeholder
Live news integration will plug into IntelligenceService in a future sprint.
AI Research
AI research placeholder
Consensus and research briefs will reuse Market Terminal research providers without changing that module.
Competition Exposure
AI Investment Championship · Week 5
Owned by
0
Competitors
5
Largest owner
—
Average weight
—
Not currently owned
No competitor holds this ticker in the latest week.
Historical ownership
No historical ownership in available weeks.
Most recent trade
No recorded trades for this ticker in the competition.